Controlled Release Formulation and Minimally Invasive Method of Administration to Locally Treat Cancer
Copyright © Targeted News Service 2024
2024-04-16
ALEXANDRIA, Virginia, April 16 -- ZETAGEN THERAPEUTICS, INC., Syracuse, New York has been assigned a patent (No. US 11957676 B1, initially filed Aug. 7, 2023) developed by Bryan S. Margulies, Liverpool, New York, for "Controlled release formulation and minimally invasive method of administration to locally treat cancer." . . .